Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Amyloid β(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

Schoonenboom, N. S.M., Pijnenburg, Y. A.L., Mulder, C., Rosso, S. M., Van Elk, E. -J., Van Kamp, G. J., Van Swieten, J. C., Scheltens, Ph. · 2004 · Neurology

Abstract

OBJECTIVE: To determine the diagnostic value of CSF amyloid beta(1-42) (Abeta42), CSF total tau, and CSF tau phosphorylated at threonine-181 (Ptau-181) in early-onset Alzheimer disease (EAD) vs frontotemporal lobar degeneration (FTLD). METHODS: Levels of Abeta42, total tau, and Ptau-181 in CSF were measured using commercially available ELISA in 47 EAD patients, 28 FTLD patients, and 21 nondemented control subjects. RESULTS: CSF Abeta42 was significantly lower and CSF total tau and CSF Ptau-181 significantly higher in EAD patients than FTLD patients and control subjects. There was an increase in diagnostic accuracy for CSF Ptau-181 vs CSF total tau (p = 0.067). Combining low CSF Abeta42 and high CSF Ptau-181 allowed EAD patients to be distinguished from FTLD patients with a sensitivity of 72% and a specificity of 93%. Logistic regression analysis with CSF Abeta42 and CSF Ptau-181 as independent continuous variables resulted in correct classification of 46 of 47 (98%) EAD patients and 23 of 28 (82%) FTLD patients. The diagnostic accuracy for EAD was independent of gender, disease duration, and disease severity. CONCLUSION: The combination of CSF Abeta42 and CSF Ptau-181 may help in differentiating EAD from FTLD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000123249.58898.e0

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 181

Metadata

Authors
Schoonenboom, N. S. M., Pijnenburg, Y. A. L., Mulder, C., Rosso, S. M., Van Elk, E. J., Van Kamp, G. J., Van Swieten, J. C., & Scheltens, P.
Venue
Neurology
Published
2004-05-11
Volume
62
Issue
9
Pages
1580-1584
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2010584905
Cited by
181
References
8
FWCI
8.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid β(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. https://app.cochat.ai/papers/10.1212/01.wnl.0000123249.58898.e0
The paper
Schoonenboom, N. S. M., Pijnenburg, Y. A. L., Mulder, C., Rosso, S. M., Van Elk, E. J., Van Kamp, G. J., Van Swieten, J. C., & Scheltens, P. (2004). Amyloid β(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology. https://doi.org/10.1212/01.wnl.0000123249.58898.e0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.